Identification of a unique set of genes altered during cell-cell contact in an in vitro model of prostate cancer bone metastasis

International Journal of Molecular Medicine

Volumn 17, Issue 5, 2006, Pages 849-856

  Wang, Jun ^a   Levenson, Anait S ^a   Satcher Jr , Robert L ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Bone marrow stromal cells; Bone metastasis; Cell cell contact; Gene expression profile; Prostate cancer

Indexed keywords

ANIMAL; ARTICLE; BONE MARROW CELL; BONE TUMOR; CELL COMMUNICATION; COCULTURE; CYTOLOGY; DNA MICROARRAY; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENETICS; HUMAN; MALE; METABOLISM; METASTASIS; METHODOLOGY; PATHOLOGY; PHYSIOLOGY; PROSTATE TUMOR; RAT; REPRODUCIBILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT; STROMA CELL; TUMOR CELL LINE;

ANIMALS; BONE MARROW CELLS; BONE NEOPLASMS; CELL COMMUNICATION; CELL LINE, TUMOR; COCULTURE TECHNIQUES; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; HUMANS; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROSTATIC NEOPLASMS; RATS; RATS, SPRAGUE-DAWLEY; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STROMAL CELLS;

EID: 33750595706     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.17.5.849     Document Type: Article

References (34)

1. Jemal A, Tiwari RC, Murray T, et al: Cancer statistics, 2004. CA: Cancer J Clin 54: 8-29, 2004.
2. Koutsilieris M, Laroche B, Thabet M, et al: The assessment of disease aggressivity in stage D2 prostate cancer patients. Anticancer Res 10: 333-336, 2001.
3. Mundy GR: Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer 2: 584-593, 2002.
4. Logothetis CJ and Lin S-H: Osteoblasts in prostate cancer metastasis to bone. Nat Rev Cancer 5: 21-28, 2005.
5. Martinez J, Silva S and Santibanez JF: Prostate-derived soluble factors block osteoblast differentiation in culture. J Cell Biochem 61: 18-25, 1996.
6. Kido J, Yamauchi N, Ohishi K, et al: Inhibition of osteoblastic cell differentiation by conditioned medium derived from the human prostate cancer cell line PC-3 in vitro. J Cell Biochem 67: 248-256, 1997.
7. Festuccia C, Bologna M, Gravina GL, et al: Osteoblast conditioned media contain TGF-beta1 and modulate the migration of prostate tumor cells and their interactions with extracellular matrix components. Int J Cancer 81: 395-403, 1999.
8. Hullinger TG, Taichman RS, Linseman DA, et al: Secretary products from PC-3 and MCF-7 tumor cell lines up-regulate osteopontin in MC3T3-E1 cells. J Cell Biochem 78: 607-616, 2000.
9. Andersen H, Jensen ON and Eriksen EF: A proteome study of secreted prostatic factors affecting osteoblastic activity: identification and characterization of cyclophilin A. Eur J Cancer 39: 989-995, 2003. (Pubitemid 36428632)
10. Bhattacharyya RS and Stern PH: IGF-I and MAP kinase involvement in the stimulatory effects of LNCaP prostate cancer cell conditioned media on cell proliferation and protein synthesis in MC3T3-E1 osteoblastic cells. J Cell Biochem 90: 925-937, 2003.
11. Yang J, Fizazi K, Peleg S, et al: Prostate cancer cells induce osteoblast differentiation through a Cbfa1-dependent pathway. Cancer Res 61: 5652-5659, 2001.
12. Pinski J, Parikh A, Bova GS, et al: Therapeutic implications of enhanced G(0)/G(1) checkpoint control induced by coculture of prostate cancer cells with osteoblasts. Cancer Res 61: 6372-6376, 2001.
13. Fizazi K, Yang J, Peleg S, et al: Prostate cancer cells-osteoblast interaction shifts expression of growth/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblasts. Clin Cancer Res 9: 2587-2597, 2003.
14. Bhattacharyya RS and Stern PH: MAP kinase involvement in responses of osteoblasts and bone to LNCaP prostate cancer cells. Oncology 17 (Suppl 3): 22, 2003.
15. Barille S, Collette M, Bataille R, et al: Myeloma cells upregulate interleukin-6 secretion in osteoblastic cells through cell-to-cell contact but down-regulate osteocalcin. Blood 86: 3151-3159, 1995.
16. Suzuki S, Sato M, Senoo H, et al: Direct cell-cell interaction enhances pro-MMP-2 production and activation in co-culture of laryngeal cancer cells and fibroblasts: involvement of EMMPRIN and MT1-MMP. Exp Cell Res 293: 259-266, 2004.
17. Satcher RL, Dvorkin K, Levenson AS, et al: Gene expression in cancer cells is influenced by contact with bone cells in a novel coculture system that models bone metastasis. Clin Orthopaedic Related Res 426: 54-63, 2004.
18. Levenson AS, Tonetti DA and Jordan VC: The oestrogen-like effect of 4-hydroxytamoxifen on induction of transforming growth factor alpha mRNA in MDA-MB-231 breast cancer cells stably expressing the oestrogen receptor. Br J Cancer 77: 1812-1819, 1998.
19. Achbarou A, Kaiser S, Tremblay G, et al: Urokinase overproduction results in increased skeletal metastasis by prostate cancer cells in vivo. Cancer Res 54: 2372-2377, 1994.
20. Cher ML, Biliran HR Jr, Bhagat S, et al: Maspin expression inhibits osteolysis, tumor growth, and angiogenesis in a model of prostate cancer bone metastasis. Proc Natl Acad Sci USA 100: 7847-7852, 2003.
21. Stewart DA, Cooper CR and Sikes RA: Changes in extracellular matrix (ECM) and ECM-associated proteins in the metastatic progression of prostate cancer. Reprod Biol Endocrinol 2: 2-14, 2004.
22. Nemeth JA, Yousif R, Herzog M, et al: Matrix metalloproteinase activity, bone matrix turnover, and tumor cell proliferation in prostate cancer bone metastasis. J Natl Cancer Inst 94: 17-25, 2002.
23. Gohji K, Fujimoto N, Hara I, et al: Serum matrix metalloproteinase- 2 and its density in men with prostate cancer as a new predictor of disease extension. Int J Cancer 79: 96-101, 1998.
24. Moses MA, Wiederschain D, Loughlin KR, et al: Increased incidence of matrix metalloproteinases in urine of cancer patients. Cancer Res 58: 1395-1399, 1998.
25. Saftig P, Hunziker E, Wehmeyer O, et al: Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice. Proc Natl Acad Sci USA 95: 13453-13458, 1998.
26. Brubaker KD, Vessella RL, True LD, et al: Cathepsin K mRNA and protein expression in prostate cancer progression. J Bone Mine Res 18: 222-230, 2003.
27. Littlewood-Evans AJ, Bilbe G, Bowler WB, et al: The osteoclast-associate protease cathepsin K is expressed in human breast carcinoma. Cancer Res 57: 5386-5390, 1997.
28. Corey E, Brown LG, Quinn JE, et al: Zoledronic acid exhibits inhibitory effects on osteoblastic and osteolytic metastases of prostate cancer. Clin Cancer Res 9: 295-306, 2003.
29. Festuccia C, Angelucci A, Gravina GL, et al: Osteoblast-derived TGF-beta1 modulates matrix degrading protease expression and activity in prostate cancer cells. Int J Cancer 85: 407-415, 2000.
30. Harris SE, Bonewald LF, Harris MA, et al: Effects of transforming growth factor beta on bone nodule formation and expression of bone morphogenetic protein 2, osteocalcin, osteopontin, alkaline phosphatase, and type I collagen mRNA in long-term cultures of fetal rat calvarial osteoblasts. J Bone Mine Res 9: 855-863, 1994.
31. Li L, Yu H, Schumacher F, et al: Relation of serum insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 to risk of prostate cancer. Cancer Causes Control 14: 721-726, 2003.
32. Mahoney MG, Simpson A, Jost M, et al: Metastasis-associated protein (MTA)-1 enhances migration, invasion, and anchorage-independent survival of immortalized human keratinocytes. Oncogene 21: 2161-2170, 2002.
33. Grill C, Gheyas F, Dayananth P, et al: Analysis of the ERK1,2 transcriptome in mammary epithelial cells. Biochem J 381: 635-644, 2004.
34. Yoshida BA, Dubauskas Z, Chekmareva MA, et al: Mitogen-activated protein kinase kinase 4/stress-activated protein/Erk kinase 1 (MKK4/SEK1), a prostate cancer metastasis suppressor gene encoded by human chromosome 17. Cancer Res 59: 5483-5487, 1999.